Brain-machine interfaces have long been a technological dream, shouldering hope of bringing communication and movement to paralysed people. However, the need to drill into a patient’s skull in order to deliver these interfaces had held back advancements in the field for years.
Synchron, founded in 2016, is the first company to propose a safer delivery method via the jugular vein. Its proposition does not require heavily invasive surgery, and the interfaces may be used in a wide range of paralysis cases. The intended result is the ability to send texts and emails, and access online services such as health appointments and banking, all with the power of thought.
The company’s technology earned FDA approval in 2021, with its work backed by top research institutes in the field. Synchron has hopes that its final showpiece may be whole-brain data transfer, but for now, its focus on giving communication to the millions of paralysis patients in the world represents a market opportunity in the tens of billions
Kirsty
Company Specialist at Welcome to the Jungle